Advertisement
News
Subscribe to MDT Magazine News

The Imaging Product Lifecycle: Why Does it Take So Long?

February 14, 2011 4:33 am | by Diagnostic Imaging | Comments

A recent article in the Journal of American College of Radiology explains why it takes so long for new imaging technologies to make their way into the radiology suite. For starters, escalating U.S. government requirements mean that imaging advances take even longer to push through than in...

TOPICS:

PerkinElmer picks up Germany's chemagen

February 14, 2011 4:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Waltham-based PerkinElmer Inc. has acquired chemagen Biopolymer-Technologie AG, Germany-based maker of automated nucleic acid isolation with operations in Worcester, for an undisclosed amount.

TOPICS:

Emergency Medical Services goes private for $3.2B

February 14, 2011 3:45 am | by The Associated Press | Comments

Ambulance services provider Emergency Medical Services Corp. says it will sell itself to private equity firm Clayton, Dubilier & Rice at a discounted price of $64 per share, or about $3.2 billion.EMS says its board has accepted the offer, which comes at a 9.4 percent discount to its Friday...

Advertisement

The Only Chromogenic Medium That Detects Both Salmonella and Shigella!

February 14, 2011 3:32 am | Comments

SANTA MARIA, Calif., Feb. 14, 2011 /- Hardy Diagnostics, an ISO certified biomedical firm, is pleased to announce the release of HardyCHROM™ SS, a highly selective chromogenic medium recommended for use as a primary screening medium for the isolation and differentiation of...

ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.

February 14, 2011 12:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 14, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it has entered into a definitive agreement to acquire SynthRx, Inc. (SynthRx), a private biotechnology company developing a purified form of a rheologic and antithrombotic agent, poloxamer...

TOPICS:

Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16

February 13, 2011 10:33 pm | by Bio-Medicine.Org | Comments

SEATTLE, Feb. 14, 2011 /- On Wednesday, February 16, 2011, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the Company's 2010 fourth quarter and...

TOPICS:

Obesity takes heavy toll on knee arthritis

February 13, 2011 8:32 pm | by EurekAlert | Comments

(American Academy of Orthopaedic Surgeons) More than 14 million visits were made to physicians' offices in 2008 by patients with knee problems. Five new studies presented at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons look at the effect that obesity has on knee...

TOPICS:

Nerves Light Up to Warn Surgeons Away

February 13, 2011 7:33 pm | by Massachusetts Institute of Technology | Comments

Tagging nerves with fluorescent markers could help surgeons avoid harming them.

TOPICS:
Advertisement

Ultrasound Industry Expert, Chris Daft, Joins Samplify Systems

February 13, 2011 5:33 pm | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Feb. 13, 2011 /- Samplify Systems, Inc., a leading provider of technology, semiconductors and sub-systems for the ultrasound equipment market, announced today that Chris Daft, Ph.D. has joined the company as Senior Scientist, where he will apply his expertise to...

TOPICS:

ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts(2)

February 12, 2011 5:33 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 12, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it will hold a conference call on Monday, February 14th, 2011 at 8:30am Eastern Time to provide an update regarding its pipeline expansion efforts. Interested parties may access the...

TOPICS:

ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts

February 12, 2011 4:35 pm | Comments

SAN DIEGO, Feb. 12, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it will hold a conference call on Monday, February 14th, 2011 at 8:30am Eastern Time to provide an update regarding its pipeline expansion efforts. Interested parties may access the...

STMicroelectronics and bTendo to develop the world?s smallest focus-free embedded Pico-Projector for next-generation smart phones

February 11, 2011 8:36 pm | by I-Micronews | Comments

Small-screen smart phones will be able to project movies and pictures to enable sharing and better viewing

Tra Warning Letter Cites Lack of GMP Procedures, Controls

February 11, 2011 2:31 pm | by U.S. Food & Drug Administration | Comments

An FDA inspection of Tra & Accessories found failures in its control of design, purchasing and the warehouse environment for products, resulting in a warning letter.

TOPICS:

Breast Implant Panel Requested, FDA Oversight Questioned

February 11, 2011 2:30 pm | by U.S. Food & Drug Administration | Comments

Rep. Rosa DeLauro (D-Conn.) is “strongly urging” CDRH to hold an advisory committee meeting to release all available information on 10-year postmarket study results for saline breast implants and address issues with FDA oversight of the trials.

TOPICS:

Biogen board approves $20 million buyback plan

February 11, 2011 12:45 pm | by The Associated Press | Comments

Biogen Idec Inc. said Friday its board of directors approved a plan to buy back up to 20 million shares of common stock.The company said it expects the buyback plan to offset common stock issuances under its share-based compensation plans, according to a filing with the Securities and Exchange...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading